A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder
Clinical trial NCT06878976 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06878976
- Sponsor
- Axsome Therapeutics, Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-20
- Primary completion
- 2027-12-01
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.